Sign in

CIK 0001178253

  • Non-accelerated filer
  • Smaller reporting company

SCYNEXIS INC

Sign in to watch
Ticker
SCYX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
562181648
Phone
+1 201-884-5485
Business address
1 EVERTRUST PLAZA, 13TH FLOOR, JERSEY CITY, NJ, 07302-6548
  1. 4 Grant or award General Counsel acquired 100,000 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 125,000 shares (grant or award)
  3. 4 Grant or award Chief Medical Officer acquired 150,000 shares (grant or award)
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market buy Chief Executive Officer bought 25,000 shares at $0.69 ($17,250)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy Chief Executive Officer bought 25,000 shares at $0.46 ($11,500)
  13. 4 Open-market buy Chief Medical Officer bought 12,000 shares at $0.50 ($5,951)
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market buy Chief Medical Officer bought 7,000 shares at $1.27 ($8,890)
  16. 4 Open-market buy Chief Executive Officer bought 25,000 shares at $1.29 ($32,250)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 16 · 314 filings